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Abstract 
We investigated a family of horses exhibiting irregular vertical stripes in their hair coat 
texture along the neck, back, hindquarters, and upper legs. This phenotype is termed 
“brindle” by horse breeders. We propose the term “brindle 1 (BR1)” for this specific 
form of brindle. In some BR1 horses the stripes were also differentially pigmented. 
Pedigree analyses were suggestive of a monogenic X-chromosomal semi-dominant 
mode of inheritance. Haplotype analyses identified a 5 Mb candidate region on 
chromosome X. Whole genome sequencing of 4 BR1 and 60 non-brindle horses 
identified 61 private variants in the critical interval, none of them located in an exon of 
an annotated gene. However, one of the private variants was close to an exon/intron 
boundary in intron 10 of the MBPTS2 gene encoding the membrane bound transcription 
factor peptidase, site 2 (c.1437+4T>C). Different coding variants in this gene lead to 
three related genodermatoses in human patients. We therefore analyzed MBPTS2 
transcripts in skin and identified an aberrant transcript in a BR1 horse, which lacked 
the entire exon 10 and parts of exon 11. The MBPTS2:c1437+4T>C variant showed 
perfect co-segregation with the brindle phenotype in the investigated family and was 
absent from 457 control horses of diverse breeds. Altogether, our genetic data and the 
previous knowledge on MBTPS2 function in the skin suggest that the identified 
MBTPS2 intronic variant leads to partial exon skipping and causes the BR1 phenotype 
in horses. 
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Introduction 
In heterozygous females, X-linked skin conditions frequently result in a characteristic 
patterning of the skin, following the so-called lines of Blaschko (Happle, 2006; Molho-
Pessach et al. 2011; Happle, 2016). The Blaschko lines describe stripes of affected skin 
follow specific patterns along lines of the body. These lines, S-shaped on the side of 
the body, and V-shaped on the back, follow the trajectory of cell migration and 
proliferation during embryogenesis. These characteristic patterns are the result of X-
chromosome inactivation (also called lyonization). In heterozygous females, the lesions 
are restricted to skin areas that derive from cell clones, in which the wildtype X-
chromosome has become inactivated and only the mutant X-chromosome is expressed. 
X-chromosome inactivation thus leads to functional mosaicism and explains different 
patterns that do not correspond to the nervous, muscular, or lymphatic system (Happle, 
2006; Sun and Tsao, 2008). Examples of human X-linked genodermatoses showing this 
phenomenon are incontinentia pigmenti, focal dermal hypoplasia, and hypohidrotic 
ectodermal dysplasia (The International Incontinentia Pigmenti Consortium, 2000; 
Grzeschik et al. 2007; Wang et al. 2007; Kere et al., 1996). 
The investigation of spontaneous domestic animal mutants displaying skin phenotypes 
can yield new insights into the functions of genes during epidermal development or in 
the regulation of skin homeostasis (Drögemüller et al. 2008; Jagannathan et al. 2013, 
Drögemüller et al. 2014). We previously reported X-linked skin conditions, which lead 
to striped patterns including the streaked hairlessness in Italian Pezzata Rossa cattle, 
which is caused by a TSR2 splice site variant (Murgiano et al. 2015) and incontinentia 
pigmenti in horses, which is caused by an IKBKG nonsense variant (Towers et al. 
2013). Horses with incontinentia pigmenti display pruritic, exudative skin lesions soon 
after birth. These develop into wart-like lesions and areas of alopecia. Affected horses 
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also have streaks of darker and lighter coat coloration from birth. These cutaneous 
manifestations in horses with incontinentia pigmenti follow the lines of Blaschko 
(Towers et al. 2013). In the horse family segregating for incontinentia pigmenti, an 
independent, but closely related phenotype with a striped coat texture pattern has long 
been recognized by breeders and termed brindle. The term brindle has been used for 
similar phenotypes in different breeds and may in fact refer to horses with different 
genetic alterations including rare spontaneous chimeras (Sponenberg, 2009). Due to the 
ambiguities associated with the term brindle, we will use the term brindle 1 (BR1) for 
the specific brindle pattern observed in the investigated family. 
In contrast to horses with incontinentia pigmenti, BR1 horses do not show any hoof or 
teeth abnormalities. The aim of the present study was to characterize the genetics 
underlying the BR1 phenotype. As this phenotype has never been fully described in the 
scientific literature, we also present a preliminary qualitative characterization of the 
BR1 phenotype. 
 
 
 
Materials and Methods 
 
Samples and phenotypes 
Three experienced breeders submitted hair or EDTA blood samples from 39 closely 
related horses segregating both, incontinentia pigmenti (Towers et al. 2013) and the 
BR1 phenotype for this study. Most of these horses had an American Quarter Horse or 
American Paint Horse registration, but some were also registered as warmblood horses. 
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The phenotype classification into BR1 and control horses was based on the breeders’ 
reports. 
We additionally used samples from 457 unrelated horses from diverse breeds not 
suspected to have the BR1 phenotype, which had been collected in the course of other 
projects at the Institute of Genetics of the University of Bern. We isolated genomic 
DNA from hair roots or EDTA blood samples according to standard procedures. 
 
Hair samples and hair morphology analyses 
One breeder submitted hairs of lesional and non-lesional areas from 4 female BR1 
horses (UKH11, UKH15, UKH21, and UKH23) in separately labeled bags for 
macroscopic and microscopic examination. Non-lesional was defined as hair from the 
base colored or normal textured coat and “lesional” was defined as hair from the 
phenotypically different coat stripes (abnormal texture and striping as seen in Figures 
1 & 2). Samples were coded by one investigator (Petra Roosje). Another investigator 
(Pierre Balmer) analyzed the macroscopic and microscopic appearance without 
knowing whether they came from lesional or non-lesional areas. The following 
parameters were quantitatively assessed in three hairs from each sample: Length of the 
hairs, surface area of the roots, diameter of the hair shafts at four different positions 
(25% of shaft length, 50% of shaft length, 75% of shaft length, tip of the hair, where 
the medulla ends), and diameter of the root. Student’s t-tests with a significance 
threshold of p = 0.05 were performed for statistical analysis. In addition to the 
quantitative parameters, the curvature of the hairs shafts was also assessed qualitatively. 
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Skin biopsies and histopathological examination 
Two six millimeter punch biopsies were obtained from the skin of a BR1 horse 
(UKH04) after local anesthesia with 2% lidocaine. The biopsies were collected from 
the lesional streaks and from normal (non-lesional) areas. Biopsies were fixed in 4% 
buffered formalin, routinely processed, and stained with haematoxylin and eosin prior 
to histopathological examination. Two further biopsies from comparable sites on the 
same horse were submerged in RNAlater solution for subsequent RNA isolation. 
 
Genotyping 
Genotyping of 22 BR1 and 14 control horses was performed by Geneseek/Neogen 
using the illumina Equine SNP70 chip containing 73,774 evenly distributed SNPs. 
 
Haplotype reconstruction 
We used LINKPHASE3 (Druet and Georges, 2015) to reconstruct haplotypes in the 
genotyped pedigree based on Mendelian segregation rules and linkage information. 
Detailed information on the methodology and modifications required to analyze the X-
chromosome are described in the File S1. 
 
Whole genome re-sequencing, SNP and short indel calling 
We prepared PCR free genomic fragment libraries with 350 bp insert size and collected 
roughly 20x coverage data on an Illumina HiSeq2500 or HiSeq3000 instrument (2×100, 
2x125 or 2x150 bp). Sequence reads were mapped to the horse reference genome and 
aligned using Burrows-Wheeler Aligner (BWA) version 0.5.9-r16 (Li and Durbin, 
2009) with default settings. The SAM file generated by BWA was then converted to 
BAM and the reads sorted by chromosome using samtools (Li et al. 2011). PCR 
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duplicates were marked using Picard tools (http://sourceforge.net/projects/picard/). We 
used the Genome Analysis Tool Kit (GATK version 2.4.9, 50) to perform local 
realignment and to produce a cleaned BAM file. Variant calls were then made with the 
Unified Genotyper module of GATK (McKenna et al. 2010). The variant data for each 
sample was obtained in variant call format (version 4.0) as raw calls for all samples and 
sites flagged using the variant filtration module of GATK. Variant filtration was 
performed, following best practice documentation of GATK version 4. The snpEFF 
software (Cingolani et al. 2012) together with the EquCab 2.0 annotation was used to 
predict the functional effects of detected variants. 
 
Structural variant calling 
We used the Delly package (Rausch et al. 2012) to look for larger deletions in the 
sequenced family trio, using daughter and mother as case and the father as control. 
Delly uses paired-ends and split-reads to sensitively and accurately delineate genomic 
rearrangements throughout the genome. Delly was ran 4 times, each time the command 
line contained either the DEL, DUP, INV or TRA command after the –t command, that 
specifies the request to look for deletions, tandem duplications, inversions and 
translocations respectively. 
To identify whether copy number variation was associated with the BR1 phenotype, we 
used the software PennCNV (Wang et al. 2007). PennCNV uses a hidden Markov 
model based approach that takes into account signal intensity, allelic intensity ratio, 
distance between markers and allele frequency to call CNVs. We built the input 
consisting into the PFB file, the intensity file and GCModel file from the data obtained 
from the manufacturer, using 22 animals present in one single SNP batch. 
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Sanger sequencing 
The associated MBTPS2 variant was genotyped by re-sequencing of targeted PCR 
products (forward-primer: GCTACTCCAATTTTCAAGCGT, reverse-primer: 
TCCCTGCCACATCTTAACCT) using Sanger sequencing technology. PCR products 
were amplified with AmpliTaqGold360Mastermix (Life Technologies) and the 
products directly sequenced using the PCR primers on an ABI 3730 capillary sequencer 
(Life Technologies) after treatment with exonuclease I and shrimp alkaline 
phosphatase. Sequence data were analyzed using Sequencher 5.1 (GeneCodes). 
 
In silico splice site analysis 
We used the “Splice-Site Analyzer Tool”, for a computational analysis of the strength 
of the wildtype and mutant 5’-splice sites of the equine MBTPS2 gene. This program is 
freely available on the internet (http://ibis.tau.ac.il/ssat/SpliceSiteFrame.htm) and 
analyzes the free energy for the binding of the primary transcript to the U1 RNA of the 
spliceosome. The program is based on a dataset of 50,493 homologous human-mouse 
internal exons (Carmel et al. 2004). 
 
RT-PCR 
The RNA was extracted from skin tissues using the RNeasy mini kit (Qiagen). The 
tissue was first finely crushed in TRIZOL (Ambion) using mechanical means, 
chloroform was then added and the RNA was separated by centrifugation. The RNA 
was cleared of genomic DNA contamination using the Quantitect Reverse 
Transcription Kit (Qiagen). The same kit was used to synthetize cDNA, as described 
by the manufacturer. An RT-PCR was carried out using primer MBTPS2_Ex8_F, 
ACAAACGGCTAGATGGTTCG, located in exon 8 and primer MBTPS2_Ex11_R, 
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ATCCACTGTCCATCCAAAGC, located in exon 11 of the MBTPS2 gene. The 
products were analyzed on a Fragment AnalyzerTM capillary gel electrophoresis 
instrument (Advanced Analytical). To estimate the proportion of the aberrant MBTPS2 
transcript, we divided the peak area of the smaller MBTPS2 band by the sum of the 
peak areas of both MBTPS2 bands. The sequence of the obtained PCR product was 
confirmed by Sanger sequencing as described above. All numbering within the equine 
MBTPS2 gene was done with respect to the reference transcript, Genbank accession 
XM_005614038.2. 
 
Data availability 
Figure S1 shows the Sanger sequence data of MBTPS2 transcripts. File S1 describes 
the detailed methodology for the haplotype analyses. Table S1 gives the gene 
annotation of the BR1 critical interval on the X chromosome as taken from NCBI 
MapViewer and the EquCab 2 assembly. Table S2 contains the complete list of 61 BR1-
associated genetic variants in the critical interval. Table S3 provides a list of the 
numbers and breeds of the 457 control horses used for the genetic association study. 
The whole genome sequencing data from 64 horses were deposited at the European 
Nucleotide Archive. The accession numbers are listed in Table S4. 
 
 
Results 
 
Qualitative phenotype description 
We previously reported a family of horses segregating incontinentia pigmenti 
characterized by consecutive characteristic stages (cutaneous pruritic, exudative lesions 
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at birth, later on wart like lesions, additional tooth, hoof and ocular anomalies; Towers 
et al. 2013). In the same horse family, breeders observed a milder phenotype that is 
restricted to an irregular striped texture and color pattern of the hair coat (Figure 1). 
The stripes generally formed a vertical pattern from the back to the sides of the animal. 
Breeders termed this phenotype “brindle” and we suggest brindle 1 or BR1 for this 
specific form of brindle. The observed BR1 phenotypes are quite variable in intensity 
between horses and the phenotype also changes with season (summer versus winter hair 
coat). The winter coat of BR1 horses often adopted a “moth eaten” appearance (Figure 
1A). Some BR1 horses had sparse mane and tail hair. The BR1 phenotype occurred in 
horses with different base coat colors. In addition to the coat structure changes, some 
brindle horses also displayed vertical stripes of different pigmentation (Figure 2). 
 
 
Figure 1. Hair coat phenotype of BR1 horses. Vertical stripes and irregular coat are 
macroscopically visible in the (A) winter and (B) summer coat of the same BR1 mare (UKH23). 
(C) The stallion UKH38 born out of a BR1 mare did not show the pronounced striped pattern, 
but had a very sparse mane and tail. 
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Figure 2. Pigmentation phenotype of BR1 mares. (A) Pronounced alternating stripes of 
eumelanin and pheomelanin in a horse with solid coat color (UKH14). (B) The horse UKH11 
had the frame overo spotting phenotype caused by the EDNRB c.354_355delinsAG variant and 
a bay base color. This horse showed fine lines of pigmented skin in areas that would be devoid 
of melanocytes and pigmentation in non-brindle horses with the frame-overo spotting pattern. 
(C) The BR1 mare UKH004 showed only a very subtle pattern of striped pigmentation on her 
coat. (D) The same mare UKH004 showed a much more pronounced pattern of irregular 
pigmentation in her skin after clipping the hair. These photos illustrate different types of streaky 
pigmentation seen in some BR1 horses. 
 
 
 
Macroscopic examination of the hairs revealed that hairs from the streaks were less 
straight or unruly compared to the hairs from the normally pigmented and textured coat 
(Figure 3). No consistent difference in hair length, pigmentation or diameter could be 
observed between the investigated lesional and non-lesional samples. On microscopic 
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evaluation we did not find any significant differences between the lesional and non-
lesional hairs. 
 
 
 
Figure 3. Macroscopic hair phenotype. The hairs from the lesional stripes (A) are more unruly 
compared to hairs from a non-lesional area of the same BR1 horse (B). Hairs were sampled 
during winter. 
 
 
 
A histopathological examination in one brindle mare did not detect any difference 
between lesional and non-lesional skin areas. As expected at the end of winter, the vast 
majority of hair follicles were in telogen or early anagen and no difference concerning 
the pigmentation or the morphology of the hair shafts and the differentiation of the hair 
follicles was histologically evident between biopsies taken from two different locations. 
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An X-linked mechanism of inheritance 
All BR1 horses investigated during this study are descendants of a single Quarter Horse 
mare UKH22, born in 1985. We compiled a pedigree of the horses sampled for this 
study (Figure 4). Most notably, all daughters of the stallion UKH09 were reported to 
exhibit the BR1 phenotype, whereas all of his sons produced by matings with wildtype 
mares were normal. This stallion did not show the typical striped pattern of the hair 
coat, but had a sparse mane and tail. Based on the pedigree and the phenotype of the 
stallion UKH09, we hypothesized that BR1 is inherited as a monogenic X-
chromosomal semi-dominant trait. According to this hypothesis, the “typical” BR1 
phenotype with a striped coat texture pattern can only be seen in heterozygous females, 
whereas hemizygous mutant males and homozygous mutant females will primarily 
show a sparse mane and tail, but no stripes. 
 
 
 
 
 
 
 
Figure 4. Family tree of BR1 horses. Males are represented by squares, females by circles. 
Animals showing the BR1 phenotype are indicated with filled black symbols. Affected males 
do not show the striped coat texture pattern, but they have a sparse mane and tail. Symbols 
filled in half with green color indicate mares affected by incontinentia pigmenti, which was 
confirmed by genotyping the IKBKG:c.184C>T variant. Arrows indicate the animals for which 
whole genome sequences were produced. The mare UKH22, born in 1985, represents the 
putative founder of the BR1 phenotype. 
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Mapping of a candidate region 
To localize the BR1 gene, we genotyped 36 horses from our family on the equine 
illumina 70 k SNP chip. We reconstructed the haplotypes in the genotyped family and 
searched for the presence of shared haplotypes among the BR1 horses. The likelihood 
of a shared haplotype among the BR1 horses was null for all marker positions except 
for a 5 Mb segment on chromosome X spanning from positions 13,601,933 to 
18,711,357 (EquCab2 assembly; markers BIEC2-1111129 - BIEC2-1112988). Only for 
that segment, the likelihood of a shared haplotype was higher than 0.99. Thus the 
haplotype analysis confirmed our hypothesis of an X-linked mode of inheritance. There 
were 41 annotated genes in the critical interval (Table S1). 
 
Identification of the causative variant 
We sequenced the genomes of a trio consisting of a BR1 female (UKH16) together with 
her BR1 mother (UKH11) and her non-affected father (UKH029) as well as one 
additional BR1 horse (UKH04). From our previous project on incontinentia pigmenti, 
we additionally had the genome sequence of an incontinentia pigmenti horse from the 
same family, which also carried the BR1 haplotype (UKH03). Finally, we had whole 
genome sequence data from 59 additional horses from diverse breeds not suspected to 
have the BR1 phenotype, which had been obtained previously in the course of other 
projects. Thus, we had 4 female genomes predicted to be heterozygous at the BR1 locus 
and 60 control genomes, which should be either hemizygous or homozygous wildtype 
at the causative variant. Together these 64 horse genomes comprised more than 62 
million genetic variants. 
Filtering for high-confidence heterozygous single nucleotide and small indel variants, 
private to our 4 BR1 cases, yielded 61 such variants in the critical interval on the 
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X-chromosome. None of these 61 variants were located in an exon of an annotated gene 
(Table S2). A search for structural variants using the programs Delly and PennCNV did 
not identify any such variants in the critical interval. 
Visual inspection of the 61 candidate variants for their potential functional relevance 
led us to focus our attention on a single nucleotide variant g.16,391,590T>C, which 
was located at position +4 of intron 10 of the MBTPS2 gene (c.1437+4T>C). We 
confirmed the presence of this variant by Sanger sequencing (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Genomic context of the MBTPS2:c.1437+4T>C variant. (A) The 5 Mb haplotype on 
the X-chromosome, which was shared by all BR1 horses, is shown in light blue. The MBTPS2 
genomic organization and the position of the variant are indicated (exons and introns are not 
drawn to scale) (B) Screenshot of the illumina sequence reads of a brindle mare indicating the 
presence of a heterozygous T>C variant. (C) Sanger electropherograms of a homozygous 
wildtype female, a heterozygous female, and a hemizygous mutant male. 
16 
Genetic association of the MBTPS2:c.1437+4T>C variant 
We genotyped the 39 available horses from the investigated family and found perfect 
co-segregation of the variant with the BR1 phenotype. In this family we observed 14 
non-affected horses, which were homozygous or hemizygous for the wildtype allele. 
We had 21 heterozygous females. Nineteen of these heterozygous females showed the 
BR1 phenotype and in the remaining two the BR1 phenotype could not be seen due to 
the simultaneous presence of the more severe incontinentia pigmenti phenotype. 
Finally, we had 4 hemizygous mutant males with sparse mane and tail. 
We further genotyped 457 control horses from 17 genetically diverse horse and pony 
breeds for the MBTPS2:c.1437+4T>C variant (Table S3). The mutant allele did not 
occur in any of these horses. 
 
An MBTPS2 splice defect 
Due to its position next to an exon/intron boundary, we hypothesized that the 
MBTPS2:c.1437+4T>C variant might have a potential impact on the correct splicing of 
MBTPS2 transcripts and thereby cause the phenotype. An in silico analysis of the 
wildtype (CAAgtatcc) and mutant (CAAgtaccc) 5’-splice site sequences of intron 10 
predicted a slightly reduced score for the binding of the mutant 5’-splice site to the U1 
RNA of the spliceosome. Both sequences represented relatively weak 5’-splice sites. 
We performed an RT-PCR to experimentally test the consequences of the 5'-splice site 
variant. Primers located in exons 8 and 11 of the MBTPS2 gene were used to amplify 
cDNA from the skin of a BR1 horse and an unrelated control. The BR1 horse expressed 
the wildtype transcript, but also a transcript, which lacked 96 nucleotides consisting of 
the entire exon 10 and the first 20 nucleotides of exon 11, confirming the existence of 
an aberrantly spliced MBTPS2 transcript in the BR1 horse (Figure 6; Figure S1). The 
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identity of the RT-PCR bands was confirmed by direct Sanger sequencing. The 
proportion of the mutant transcript in the BR1 horse was roughly 20% and we observed 
a minimally higher proportion of mutant transcript in the skin biopsy taken from a 
lesional skin area compared to the skin biopsy taken from a non-lesional skin area. 
However, as we had only two biopsies from one horse for this analysis, it is unclear 
whether this difference is significant. The mutant transcript contained an open reading 
frame lacking 32 codons, which encode parts of the third luminal and the entire sixth 
transmembrane domain of the MBTPS2 protein (p.422_453del). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Experimental verification of the MBTPS2 splice defect. (A) The MBPTS2 transcript 
is shown. On the enlarged 3’-end of the transcript, the position of the primers used for RT-PCR 
is indicated. (B) RT-PCR was performed using skin RNA from a brindle and a control horse. 
The picture shows a Fragment AnalyzerTM gel image of the experiment. In the control animal 
(wt), only the expected 439 bp band is visible. For the brindle horse, two RNA samples from 
lesional (L) and non-lesional (NL) skin were used. In both samples, an additional 343 bp band 
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corresponding to a transcript lacking the entire exon 10 and parts of exon 11 can be seen. The 
variant designation on the transcript level thus is r.[=, 1265_1360del]. The band at the bottom 
of all three lanes with RT-PCR products corresponds to molecules of less than 50 nucleotides 
in size and probably consists of residual unused primers or primer dimers. The aberrant 343 bp 
band comprised 23% and 19% of the total transcripts in the lesional and non-lesional skin 
sample, respectively. 
 
 
 
Discussion 
In this study, we provide an initial and qualitative phenotypic description of one form 
of brindle in horses, termed “brindle 1 (BR1)”. This form of brindle is phenotypically 
quite variable and some horses are predominantly characterized by coat texture 
changes, while in others, the striped pigmentation pattern is the predominant feature. 
More comprehensive quantitative morphometric studies will be needed to fully 
characterize all changes in hair structure and pigmentation that can occur in BR1 horses. 
It will also be interesting to see whether hemizygous mutant males and homozygous 
mutant females will show some subtle alteration of their body hair in addition to their 
sparse manes and tails. 
We mapped the causative locus for this form of brindle in horses to a 5 Mb segment on 
the X-chromosome. A whole genome sequencing approach identified a single 
nucleotide variant within the 5’-splice site of intron 10 of the MBTPS2 gene. We have 
to caution that the equine reference genome assembly and annotation are not perfect, 
which impedes our variant detection sensitivity. For example the horse genome 
reference contains two gap regions within the equine MBTPS2 gene, one of them 
harboring exon 9 with 196 coding nucleotides. Thus we cannot exclude the possibility 
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that we missed one or several additional genetic variants in linkage disequilibrium with 
the 61 identified private variants. However, we can at least rule out exon 9 of the 
MBTPS2 gene as this exon was unchanged in the cDNA Sanger sequencing data from 
a BR1 horse. 
The MBTPS2:c.1437+4T>C variant perfectly co-segregated with the phenotype in an 
extended horse family and was absent from a large cohort of horses from diverse 
breeds. We further confirmed the expression of an additional aberrantly spliced 
MBTPS2 transcript in the skin of a BR1 horse. 
The MBTPS2 gene encodes the membrane bound transcription factor peptidase, site 2, 
a zinc metalloprotease located in the membrane of the ER and Golgi apparatus. 
MBTPS2 cleaves sterol regulatory element binding proteins (SREBPs) within a 
transmembrane segment, releasing the amino-terminal domain of the SREBP from the 
membrane so that it can enter the nucleus and activate target genes encoding e.g. the 
low density lipoprotein receptor and enzymes for cholesterol and fatty acid biosynthesis 
(Rawson et al. 1997; Zelenski et al. 1999; Kroos and Akiyama, 2013). 
Genetic variants in MBTPS2 lead to three related genodermatoses in human patients: 
ichthyosis follicularis, atrichia and photophobia (IFAP, OMIM #308205, Oeffner et al. 
2009), Olmsted syndrome/palmoplantar keratoderma (OLMSX, OMIM #300918, 
Haghighi et al. 2013), and keratosis follicularis spinulosa decalvans (KFSDX, OMIM 
#308800, Aten et al. 2010). A detailed genotype-phenotype correlation for a large 
number of different human variants has been published (Bornholdt et al. 2013). It is 
thought that the complete absence of functional MBTPS2 is lethal. Depending on the 
specific genetic variant, male human patients carrying missense mutations in the 
MBTPS2 gene mostly show quite severe phenotypes, sometimes with additional 
developmental aberrations and/or mental retardation in addition to the skin changes 
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termed BRESEK/BRESHECK syndrome (Reish et al. 1997). Females carrying any of 
these MBTPS2 gene variants in heterozygous state show skin changes of varying 
severity that follow the lines of Blaschko or no visible phenotype at all. Male human 
IFAP patients with intronic MBTPS2 variants affecting splicing were reported. 
Unfortunately, RNA of these patients was not available and it is therefore unknown 
which proportions of wildtype and aberrant transcripts were expressed (Oeffner et al. 
2013). 
It is not fully elucidated how MBTPS2 deficiency mechanistically causes the observed 
skin and hair changes in human patients. MBTPS2 deficiency is thought to lead to 
changes in ER stress response and sterol homeostasis including cholesterol 
biosynthesis. Several other defects in genes required for steroid and lipid metabolism 
are also associated with genodermatoses, such as e.g. ichthyoses (Feingold and Elias, 
2014). 
Based on the fact that hair morphology is altered in both BR1 horses and human patients 
with MBTPS2 variants, we propose that the observed splice defect is actually causative 
for the BR1 phenotype in horses. The BR1 phenotype is clearly much milder than the 
different phenotypes reported in human patients with coding MBTPS2 variants. We 
speculate that this might be due to the specific equine variant and the high proportion 
of wildtype transcript, which is still expressed in the skin of mutant horses. It remains 
to be investigated whether the predicted truncated MBTPS2 protein is actually 
expressed and correctly localized in BR1 horses. In this case, it could potentially exert 
a dominant-negative function in cells that express both wildtype and mutant protein 
(gain of function). On the other hand, it is also possible that the truncated protein is not 
correctly processed and rapidly degraded. In this case, BR1 horses might be lacking 
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sufficient amounts of functional MBTPS2 protein to maintain a completely normal coat 
appearance (loss of function). 
The obtained data do not definitively prove the causality of the MBTPS2:c.1437+4T>C 
variant for the BR1 phenotype. However, in our opinion, our genetic association data 
together with the experimental confirmation of altered MBTPS2 splicing and the 
previous knowledge on the biological function of MBTPS2 in skin, provide very strong 
suggestive evidence that MBTPS2:c.1437+4T>C does indeed cause the skin and hair 
coat changes seen in BR1 horses. 
In summary, we provided evidence that BR1 in horses is inherited as an 
X-chromosomal semi-dominant trait. A positional cloning approach identified the 
intronic variant c.1437+4T>C and a resulting splice defect in the MBTPS2 gene as 
candidate causative mechanism underlying the BR1 phenotype. 
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